Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Toxicol Pathol. 2018 Jun 12;46(5):574–596. doi: 10.1177/0192623318779326

Table 2.

Incidence of uterine glandular epithelial lesions over time following neonatal exposure to GEN or DES.

CON
GEN
DES
Age (mo) 2–3 6 12 18 2–3 6 12 18 2–3 6 12 18



Diagnosis Incidence (%) Incidence (%) Incidence (%)
Glandular cystic dilation 0/13
(0%)
2/33
(6%)
7/29
(24%)
15/30
(50%)
0/10
(0%)
12/30b
(40%)
23/30c§
(77%)
27/30b
(90%)
0/9
(0%)
4/31
(13%)
10/26
(38%)
29/30c
(97%)
Adenomyosis 0/13
(0%)
0/33
(0%)
3/29
(10%)
4/30
(13%)
1/10
(10%)
6/30b
(20%)
10/30
(33%)
13/30a
(43%)
1/9
(11%)
13/31c
(42%)
13/26b
(50%)
18/30c
(60%)
Squamous metaplasia 0/13
(0%)
1/33
(3%)
0/29
(0%)
0/30
(0%)
0/10
(0%)
11/30c
(37%)
16/30c
(53%)
24/30c§
(80%)
0/9
(0%)
7/31a
(23%)
12/26c
46%
14/30c
(47%)
 Severity grade 0.0 0.0 0.0 0.0 0.0 0.4 0.8 1.2 0.0 0.3 0.6 0.8
Basal cell metaplasia 1/13
(8%)
3/33
(9%)
2/29
(7%)
0/30
(0%)
7/10b
(70%)
19/30c
(63%)
26/30c
(87%)
30/30c
(100%)
8/9c
(89%)
30/31c
(97%)
25/26c
(96%)
29/30c
(97%)
 Severity grade 0.1 0.1 0.1 0.0 0.7 0.7 1.7 1.7 0.9 1.5 2.0 1.7
Atypical hyperplasia 0/13
(0%)
0/33
(0%)
0/29
(0%)
0/30
(0%)
0/10
(0%)
3/30
(10%)
9/30b
(30%)
15/30c
(50%)
0/9
(0%)
14/31c
(45%)
14/26c
(54%)
18/30c
(60%)
Carcinoma 0/13
(0%)
0/33
(0%)
0/29
(0%)
0/30
(0%)
0/10
(0%)
2/30
(7%)
7/30a
(23%)
10/30c
(33%)
0/9
(0%)
5/31a
(16%)
9/26b
(35%)
12/30c
(40%)

Incidence data for 6, 12, and 18 mo time points were previously reported by Suen et al. 2016.

Abbreviations: CON, control; GEN, genistein; DES, diethylstilbestrol

Severity values indicate average grade across the entire group (0-4).

Letters indicate

a

P<0.05,

b

P<0.01, and

c

P<0.001 compared with corresponding age-matched control group using a two-tailed Fisher exact test.

Symbols indicate

§

P<0.05 and

P<0.01 compared with corresponding age-matched DES group using a two-tailed Fisher exact test.